Sunscreen TEA Review Deadlines In Limbo In House, Default Approvals Cut
This article was originally published in The Tan Sheet
Executive Summary
The House Energy and Commerce Health subcommittee unanimously advances the Sunscreen Innovation Act to full committee, but provisions in the bill seeking a tight timeline for FDA’s review of sunscreen ingredient TEAs are in limbo, according to the Public Access to Sunscreens coalition of stakeholders.